Mansi, Matthew

Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines

Mansi, M., Howley, R., Chandratre, S., & Chen, B. (2022) · Biochemical Pharmacology

Photodynamic Therapy Research StudiesDrug Transport and Resistance Mechanisms

Cited by 38

Evaluation of aminolevulinic acid-mediated protoporphyrin IX fluorescence and enhancement by ABCG2 inhibitors in renal cell carcinoma cells

Howley, R., Mansi, M., Shinde, J., Restrepo, J., & Chen, B. (2020) · Journal of Photochemistry and Photobiology B: Biology

Photodynamic Therapy Research StudiesPorphyrin Metabolism and Disorders

Cited by 25

Ferrochelatase Deficiency Abrogated the Enhancement of Aminolevulinic Acid‐mediated Protoporphyrin IX by Iron Chelator Deferoxamine

Palasuberniam, P., Kraus, D., Mansi, M., Braun, A., Howley, R., Myers, K. A., & Chen, B. (2019) · Photochemistry and Photobiology

Photodynamic Therapy Research StudiesPorphyrin Metabolism and Disorders

Cited by 23

Small molecule kinase inhibitors enhance aminolevulinic acid-mediated protoporphyrin IX fluorescence and PDT response in triple negative breast cancer cell lines

Palasuberniam, P., Kraus, D., Mansi, M. S., Howley, R., Braun, A., Myers, K. A., & Chen, B. (2021) · Journal of Biomedical Optics

Photodynamic Therapy Research StudiesNanoplatforms for cancer theranostics

Cited by 16

Analysis of Renal Cell Carcinoma Cell Response to the Enhancement of 5‐aminolevulinic Acid‐mediated Protoporphyrin IX Fluorescence by Iron Chelator Deferoxamine†

Howley, R., Mansi, M., Shinde, J., Restrepo, J., & Chen, B. (2023) · Photochemistry and Photobiology

Photodynamic Therapy Research StudiesPorphyrin Metabolism and Disorders

Cited by 8